Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

Bonnefoi, Hervé

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. [electronic resource] - The Lancet. Oncology Dec 2007 - 1071-1078 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Study; Retracted Publication

1474-5488

10.1016/S1470-2045(07)70345-5 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--chemistry
Chemotherapy, Adjuvant
Cyclophosphamide--administration & dosage
Disease-Free Survival
Docetaxel
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Gene Expression Profiling--methods
Gene Expression Regulation, Neoplastic
Genetic Testing--methods
Humans
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Oligonucleotide Array Sequence Analysis
Patient Selection
Predictive Value of Tests
ROC Curve
Receptors, Estrogen--analysis
Reproducibility of Results
Sensitivity and Specificity
Taxoids--administration & dosage
Treatment Outcome